| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-09 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.19 | 6e-09 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.2 | 8e-09 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-08 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.18 | 4e-08 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-07 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-07 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.18 | 4e-07 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-07 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |